• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Hyderus

Hyderus Cyf and Hyderus Teoranta

  • facebook
  • twitter
  • linkedin
  • medium
  • Home
  • Tell the Truth
    • Videos
  • About us
    • Access to innovative medicines
    • New Work in India
    • Mark Chataway
    • We pay our taxes
    • Our approach to managing risk perception and crises
    • African journalists we respect
  • Customers
  • Expertise
    • Development and Politics
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      • Drivers and barriers for new vaccines
    • Strategic Planning
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Contact
  • Blog
    • What we’re thinking
    • Our World
    • Staff blog
  • Flexible Pricing Plan

Mark Chataway

Hype for UN’s report on access to medicines is confused and contradictory

September 19, 2016 by Mark Chataway 1 Comment

The first sentence of the official press release for the new UN report on access to medicines captures all the problems with the report, probably inadvertently. Here is the monster sentence   Whether it’s the rising price of the EpiPen, or new outbreaks of diseases, like Ebola, Zika and yellow fever, the rising costs of health technologies … [Read more...] about Hype for UN’s report on access to medicines is confused and contradictory

Filed Under: Featured Tagged With: access to medicines, health policy, pharmaceutical industry, public health

The dangerous unreliability of quantitative market research seen in Brexit

June 27, 2016 by Mark Chataway 2 Comments

Updated on the 27th of June 2016 -- this is a re-edited version of a post we originally put on the site in December 2015   I lied to the company that runs my gym recently. I like the gym and, although I have limited contact with them, the managers seem competent and nice enough. They sent me a market research survey and my lies on it are … [Read more...] about The dangerous unreliability of quantitative market research seen in Brexit

Filed Under: Featured Tagged With: market research, opinion polling

Media training needs a radical rethink

February 26, 2016 by Mark Chataway Leave a Comment

If Donald Trump is winning primaries, we know that media training needs a radical rethink   What worked then   Clients often ask for help getting ready for interviews or press conferences. They are right to worry. Every consultant has a reel full of disasters: unprepared interviewees made to look foolish or dishonest by a … [Read more...] about Media training needs a radical rethink

Filed Under: Our craft Tagged With: communication skills, communications consultancy, media, media training

India’s new medicine taxes hit the poor and the sick

February 14, 2016 by Mark Chataway 1 Comment

India surprised the world this week by announcing that it would impose taxes on many imported medicines. It will remove customs duty waivers and impose excise duty on 76 medicines used to treat cancer, HIV, haemophilia, diabetes and other diseases. The Times of India reported that this might “result in price increases between 10-25 percent on both … [Read more...] about India’s new medicine taxes hit the poor and the sick

Filed Under: Featured Tagged With: access to medicines, india, pharmaceutical industry, taxes on medicines

Policy dialogue in the Twitter age

February 11, 2016 by Mark Chataway Leave a Comment

The UN Secretary General has a High Level Panel on Access to Medicines. Helen Clark, the Administrator (Chief Executive) of UNDP and a former prime Minister of New Zealand, recorded a video for the panel members. She discussed UNDP's accomplishments in getting the price of medicines cut for African countries, including Equatorial Guinea. Equatorial … [Read more...] about Policy dialogue in the Twitter age

Filed Under: Featured Tagged With: health policy, Twitter; policy and social media

Access to advanced medicines and affordability: a look forward to 2016

January 2, 2016 by Mark Chataway 2 Comments

We think that there will be unparalleled attention in 2016 on the issues of access to advanced medicines and on how to pay for them. Past controversies have largely focussed on access in low and middle income countries; this time Europe and North America will command at least as much attention. Ironically, the world’s richest and the poorest will … [Read more...] about Access to advanced medicines and affordability: a look forward to 2016

Filed Under: Featured Tagged With: access to medicines, cancer, health policy, patents, pharmaceutical industry

Five myths about access to medicines in emerging markets

July 22, 2015 by Mark Chataway 1 Comment

Pharma companies can have an “emerging markets strategy”   Emerging markets are nothing like one another: an Argentinian denied an expensive new drug will usually just go and get a court to order his insurer or the state to pay for it; an Indonesian may never even find out what’s wrong with him.  Argentina spends about $1050 per person on … [Read more...] about Five myths about access to medicines in emerging markets

Filed Under: Our craft Tagged With: access to medicines, Global Health Progress, health policy, pharmaceutical industry

The basics about spending on health around the world

July 21, 2015 by Mark Chataway 1 Comment

Most industrialised countries use about nine percent of GDP for government health spending and about 11 percent of GDP for overall health spending (public and private combined). This chart from the World Bank (based on WHO data) shows the percentage of GDP spent by governments on health and this one the overall health spending.   The … [Read more...] about The basics about spending on health around the world

Filed Under: Our craft Tagged With: health policy, health spending, public health, WHO

The Addis deal that will “turbo charge development”

July 16, 2015 by Mark Chataway Leave a Comment

UPDATED WITH INTERNATIONAL REACTIONS The Financing for Development meeting ended last night in Addis Ababa with the UK Secretary of State for Development hailing it as "a historic international deal that takes us beyond aid." Justine Greening went on to say, "It is the first ever agreement that allows us to harness private sector investment and … [Read more...] about The Addis deal that will “turbo charge development”

Filed Under: Featured Tagged With: Africa, development assistance, ODA

The failure of global health advocacy spelled out in numbers

July 11, 2015 by Mark Chataway Leave a Comment

No fashionable university is without its own department doing studies and advocacy on global health these days and NGOs and consultancies proliferate. Richard Horton and his team at The Lancet seem to produce ever more elaborate reports and commissions demanding an extra $30 billion here or $50 billion there. None of them tell you that funding for … [Read more...] about The failure of global health advocacy spelled out in numbers

Filed Under: Featured Tagged With: advocacy, Global Health Progress, health policy, public health

  • Page 1
  • Page 2
  • Page 3
  • …
  • Page 15
  • Next Page »

Primary Sidebar

Categories

  • Featured (183)
  • Our craft (18)
  • Staff blog (56)
access to medicines Africa Alzheimer's disease China Chris Nial climate change communications consultancy Development development assistance Donald Trump environment foreign policy Global Health Progress global warming green energy health healthcare health policy HIV Hyderus india Mark Chataway ODA patents pharmaceutical industry public health vaccination vaccines wales WHO

Hyderus on Twitter

Tweets by Hyderus

Hyderus on Facebook

Videos

The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
More videos

Clients

 
 
 

Footer

Looking For?

  • Our World
  • Contact us
  • Privacy Policy
  • Terms of use

Recent Posts

  • Disease epidemiology in the world’s newest megacities
  • Vaccine Hesitancy – One of the world’s top 10 global health threats
  • Parkinson’s and the difficulty of treating neurological conditions

Copyright © 2019 Hyderus. All rights reserved. Sitemap

  • Home
  • Tell the Truth
    ▼
    • Videos
  • About us
    ▼
    • Access to innovative medicines
    • New Work in India
    • Mark Chataway
    • We pay our taxes
    • Our approach to managing risk perception and crises
    • African journalists we respect
  • Customers
  • Expertise
    ▼
    • Development and Politics
      ▼
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      ▼
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      ▼
      • Drivers and barriers for new vaccines
    • Strategic Planning
      ▼
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      ▼
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Contact
  • Blog
    ▼
    • What we’re thinking
    • Our World
    • Staff blog
  • Flexible Pricing Plan

Cookies

This site uses cookies: Find out more.